MYLINH PHAN: Open Payments
NPI 1912655804 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$63 in 3 payments from 3 companies in 2025. Trend: 2023 $504 · 2024 $233 · 2025 $63
Food & beverage: $63
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $30 |
| Eisai Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
Products named: BLENREP, Lenvima, Venclexta.
Industry payments across CA — which companies pay providers there.
